FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic CancerThierry Conroy, Jean‐Baptiste Bachet, Pascal Hammel et al.|New England Journal of Medicine|2018Cited by 2.8k
Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.Pascal Morel, Pierre Fenaux, Claude Preudhomme et al.|PubMed|1993Cited by 303